IFNA1 and infection: While the targeting of vascular IFNα or β signaling as a potential therapeutic strategy to prevent disease progression in patients with severe COVID-19 will require additional study, our findings raise a more pressing concern and reveal the mechanism regarding current treatment guidelines that propose the use of exogenous recombinant IFNα or β for the treatment of severe infection.